Results 191 to 200 of about 30,146 (272)

Experience of Myeloproliferative Neoplasms Guidelines in the United Kingdom: Perspective and International Context [PDF]

, 2016
Harrison, Claire, McMullin, Mary Frances
core   +1 more source

Duloxetine, an SNRI, Targets pSTAT3 Signaling: <i>In</i>-Silico, RNA-Seq and <i>In</i>-Vitro Evidence for a Pleiotropic Mechanism of Pain Relief. [PDF]

Int J Mol Sci
Abdi SAH, Azhar G, Zhang X, Wei JY.
europepmc   +1 more source

50342 Serum Protein Biomarkers May Reveal Clues to Early Immune Activity Upon Ruxolitinib Cream Withdrawal in the TRuE-V Long-Term Extension Study [PDF]

Angelina Volkova, David Rosmarin, Thierry Passeron, Julien Sénéschal, Albert Wolkerstorfer, Shaoceng Wei, Deanna Kornacki, Susan H. Smith   +7 more
openalex   +1 more source

Effect of ruxolitinib on the oral mucosa in steroid-refractory graft-versus-host disease: a prospective observational exploratory study. [PDF]

Clin Oral Investig
Bellido M, Jonk AE, Kaurinovic M, Biswana A, Hazenberg CLE, Choi G, Choi G, Morsink LM, Huls G, Vissink A, Delli K.   +10 more
europepmc   +1 more source

Cutaneous Lymphoma Associated with JAK Inhibitors: A Pharmacovigilance Analysis of the FAERS Database and Literature Review. [PDF]

Acta Derm Venereol
Lu L, Feng J, He H, Peng Y, Zhang S, Yang L, Liu Y, Wang T.   +7 more
europepmc   +1 more source

Pharmacokinetic Monitoring of JAK Inhibitor and Tacrolimus for Safe and Effective Management of Graft-Versus-Host Disease After Pediatric Liver Transplantation. [PDF]

Pediatr Transplant
Sawada K, Khandelwal P, Davies SM, Crooker A, Mizuno T, Asai A.   +5 more
europepmc   +1 more source

Early dermoscopic and confocal features predict response to topical ruxolitinib in nonsegmental vitiligo: A prospective observational study [PDF]

Helena Gioacchini, Giulia Veronesi, Federico Venturi, Anna Campanati, Aldo Gardini, Tommaso Bianchelli, Giovanni D’Agostino, Ana B. Rossi, Emi Dika, Anna Campanati   +9 more
openalex   +1 more source

Identification of Novel JAK2 Inhibitors from Amino Derivatives of Epoxyalantolactone: In Silico and In Vitro Studies. [PDF]

Int J Mol Sci
Todsaporn D, Sanachai K, Aonbangkhen C, Poo-Arporn RP, Kartsev V, Pukhov S, Afanasyeva S, Geronikaki A, Rungrotmongkol T.   +8 more
europepmc   +1 more source

Efficacy and safety of ruxolitinib for graft-versus-host disease prophylaxis in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Xie C, Shi L, Wei Z, Lai Y, Liu R.
europepmc   +1 more source

EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis

, 2018
Alessandro M. Vannucchi, Peter A.W. te Boekhorst, Claire Harrison, Guangsheng He, Marianna Caramella, Dietger Niederwieser, Françoise Boyer‐Perrard, Minghui Duan, Nathalie Francillard, Betty Molloy, Monika Wroclawska, Heinz Gisslinger   +11 more
openalex   +2 more sources